Press Release Aptevo Provides 2Q26 Business Update and Reports Second Quarter Financial Results Aug 14
Press Release Aptevo Therapeutics Announces Closing of Existing Warrants Exercise and PIPE for $4.5 Million Gross Proceeds Aug 13
Press Release Aptevo Therapeutics Announces Exercise of Existing Warrants and PIPE for $4.5 Million Gross Proceeds Aug 12
Press Release Aptevo Strengthens Solid Tumor Strategy with Patent Filing for Nectin-4 x PD-L1 Dual Targeting Backbone Jul 27